Report China Chemical Pharmaceutical Industry Full Version

2010 Report on China Chemical Pharmaceutical Industry

PDF USD $ 2,200
Hard Copy USD $ 2,300
Enterprise wide USD $ 3,300

Pages: 115
Tables and Figures:
Published Date: Dec , 2010
Publisher: 168 Research Group
Contact: Mr. Peter Lee 86-10-82965190 86-13161572746 [email protected]


China’s chemical pharmaceutical industry has maintained a good momentum of growth in recent years. In 2009, the number of chemical pharmaceutical manufacturers reached 2,434, up 7.5% year-on-year; the total value of industrial output achieved RMB420.7 billion, rising 10.9% year-on-year; and the pharmaceutical operating income reached RMB424.3 billion, a year-on-year increase of 19.5%.

Regarding the product structure, China is a big producer of active pharmaceutical ingredients (API). As of August 2010, China had had 1,197 active pharmaceutical ingredient manufacturers, been capable of producing over 1,500 categories of active pharmaceutical ingredients, and ranked No.1 in the world in terms of the output of penicillin, vitamins and antipyretics & analgesics. Furthermore, China is also the world’s biggest exporter of active pharmaceutical ingredients, with the export volume approximating half of the domestic output of active ingredients. From the perspective of export value, active pharmaceutical ingredient accounted for 80% of China’s total pharmaceutical export value in 2009; finished dosage form mainly addresses domestic demand, and only covered 6% of China’s total pharmaceutical export value in 2009.

China’s Pharmaceutical Export by Value, 2009

Source: General Administration of Customs,

China has many chemical pharmaceutical manufacturers, and the whole industry features a low concentration rate in general. However, the segmented markets have a higher concentration rate affected by technology, raw materials source, policy and large R&D investment of chemical pharmaceutical industry. For example, China Pharmaceutical Group Limited, Shandong Luwei Pharmaceutical Co., Ltd., Northeast Pharmaceutical Group Co., Ltd. and North China Pharmaceutical Group Corp. totally held over 90% shares in the domestic vitamin market, while Zhejiang Medicine Co., Ltd. alone covered 50% shares of the global vitamin H market in 2009.

Based on the abundant statistics, the report not only underlines the overall operation including the current development, profitability, import & export and competitive layout of China’s chemical pharmaceutical industry and its sub-sectors, but also makes an in-depth analysis of the operation and development advantages of China’s ten leading active pharmaceutical ingredient manufacturers and ten finished dosage form companies.

Northeast Pharmaceutical Group Co., Ltd., Zhejiang Medicine Co., Ltd. and Zhejiang NHU Co., Ltd. are China’s major vitamin manufacturers, as well as the key vitamin suppliers in the world. In the meantime, they are also actively expanding to produce other categories of active pharmaceutical ingredients.
2010 Report on China Chemical Pharmaceutical Industry

Get it now

Leave a Reply

Your email address will not be published. Required fields are marked *

Recommended software